Outcome of autologous stem cell transplantation in patients with favorable-risk acute myeloid leukemia in first remission

Outcome of autologous stem cell transplantation in patients with favorable-risk acute myeloid leukemia in first remission

Abstract Objective To evaluate the efficacy of autologous hematopoietic stem cell transplantation (auto-HSCT) in patients with favorable-risk acute myeloid leukemia in first remission. Method Twenty patients who received auto-HSCT at our center between January 2014 and January 2021 were retrospectiv...

Full description

Bibliographic Details
Main Authors: Juan Chen, Li Liu, Runzhi Ma, Aiming Pang, Donglin Yang, Xin Chen, Jialin Wei, Yi He, Rongli Zhang, Weihua Zhai, Qiaoling Ma, Erlie Jiang, Mingzhe Han, Jiaxi Zhou, Sizhou Feng
Format: Article
Language:English
Published: BMC 2022-10-01
Series:Cancer Cell International
Subjects:
Outcome
Autologous stem cell transplantation
Acute myeloid leukemia
Favorable-risk
Remission
Online Access:https://doi.org/10.1186/s12935-022-02750-4

Internet

https://doi.org/10.1186/s12935-022-02750-4

Similar Items